Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform
Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
When the Medicare Part D benefit was constructed, drugs for weight loss were explicitly excluded from coverage, as the limited effectiveness and unfavorable safety profile of medications available at the time failed to justify coverage of drugs perceived to be used for cosmetic purposes. In recent years, drugs activating the glucagon-like peptide-1...
Alternative Titles
Full title
Medicare Part D Coverage of Anti-obesity Medications: a Call for Forward-Looking Policy Reform
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10853087
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10853087
Other Identifiers
ISSN
0884-8734
E-ISSN
1525-1497
DOI
10.1007/s11606-023-08416-9
